🎉 M&A multiples are live!
Check it out!

Azenta Valuation Multiples

Discover revenue and EBITDA valuation multiples for Azenta and similar public comparables like Bangkok Dusit Medical Services, Sonic Healthcare, and Australian Clinical Labs.

Azenta Overview

About Azenta

Azenta Inc is a provider of life sciences solutions, enabling impactful breakthroughs and therapies to market faster. It provides a full suite of reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and cell therapies for the industry's top pharmaceutical, biotech, academic and healthcare institutions globally. The company has three reportable segments that are Sample Management Solutions, Multiomics, and B Medical Systems. It generates a substantial part of its revenue from its Sample Management Solutions segment.


Founded

1978

HQ

United States of America
Employees

3.3K+

Website

azenta.com

Financials

LTM Revenue $623M

LTM EBITDA $57.8M

EV

$853M

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Azenta Financials

Azenta has a last 12-month revenue of $623M and a last 12-month EBITDA of $57.8M.

In the most recent fiscal year, Azenta achieved revenue of $656M and an EBITDA of $17.8M.

Azenta expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Azenta valuation multiples based on analyst estimates

Azenta P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $665M $656M XXX XXX XXX
Gross Profit $256M $263M XXX XXX XXX
Gross Margin 38% 40% XXX XXX XXX
EBITDA $55.2M $17.8M XXX XXX XXX
EBITDA Margin 8% 3% XXX XXX XXX
Net Profit $2.1B -$14.3M XXX XXX XXX
Net Margin 321% -2% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Azenta Stock Performance

As of April 15, 2025, Azenta's stock price is $28.

Azenta has current market cap of $1.3B, and EV of $853M.

See Azenta trading valuation data

Azenta Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$853M $1.3B XXX XXX XXX XXX $0.46

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Azenta Valuation Multiples

As of April 15, 2025, Azenta has market cap of $1.3B and EV of $853M.

Azenta's trades at 1.4x LTM EV/Revenue multiple, and 14.8x LTM EBITDA.

Analysts estimate Azenta's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Azenta and 10K+ public comps

Azenta Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $853M XXX XXX XXX
EV/Revenue 1.3x XXX XXX XXX
EV/EBITDA 28.9x XXX XXX XXX
P/E -10.7x XXX XXX XXX
P/E/Growth n/a XXX XXX XXX
EV/FCF 64.5x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Azenta Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Azenta Valuation Multiples

Azenta's NTM/LTM revenue growth is -2%

Azenta's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Azenta's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Azenta's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Azenta and other 10K+ public comps

Azenta Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth -1% XXX XXX XXX XXX
EBITDA Margin 5% XXX XXX XXX XXX
EBITDA Growth -68% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 3% XXX XXX XXX XXX
Revenue per Employee $0.2M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue n/a XXX XXX XXX XXX
G&A Expenses to Revenue n/a XXX XXX XXX XXX
R&D Expenses to Revenue 5% XXX XXX XXX XXX
Opex to Revenue 51% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Azenta Public Comps

See public comps and valuation multiples for Laboratory Services and Genomics & Personalized Medicine comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Australian Clinical Labs XXX XXX XXX XXX XXX XXX
Healius XXX XXX XXX XXX XXX XXX
Integral Diagnostics XXX XXX XXX XXX XXX XXX
Sonic Healthcare XXX XXX XXX XXX XXX XXX
Bangkok Dusit Medical Services XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Azenta M&A and Investment Activity

Azenta acquired  XXX companies to date.

Last acquisition by Azenta was  XXXXXXXX, XXXXX XXXXX XXXXXX . Azenta acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Azenta

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Azenta

When was Azenta founded? Azenta was founded in 1978.
Where is Azenta headquartered? Azenta is headquartered in United States of America.
How many employees does Azenta have? As of today, Azenta has 3.3K+ employees.
Who is the CEO of Azenta? Azenta's CEO is Mr. John P. Marotta.
Is Azenta publicy listed? Yes, Azenta is a public company listed on NAS.
What is the stock symbol of Azenta? Azenta trades under AZTA ticker.
When did Azenta go public? Azenta went public in 1995.
Who are competitors of Azenta? Similar companies to Azenta include e.g. Australian Clinical Labs, Healius, Integral Diagnostics, Sonic Healthcare.
What is the current market cap of Azenta? Azenta's current market cap is $1.3B
What is the current revenue of Azenta? Azenta's last 12-month revenue is $623M.
What is the current EBITDA of Azenta? Azenta's last 12-month EBITDA is $57.8M.
What is the current EV/Revenue multiple of Azenta? Current revenue multiple of Azenta is 1.4x.
What is the current EV/EBITDA multiple of Azenta? Current EBITDA multiple of Azenta is 14.8x.
What is the current revenue growth of Azenta? Azenta revenue growth between 2023 and 2024 was -1%.
Is Azenta profitable? Yes, Azenta is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.